Full Text View
Tabular View
No Study Results Posted
Related Studies
Equivalence Study of Dorzolamide 2% Eye Drops Solution
This study has been completed.
Study NCT00878917   Information provided by Alfred E. Tiefenbacher (GmbH & Co. KG)

First Received on April 8, 2009.   Last Updated on February 11, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Open Angle Glaucoma
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma
Glaucoma, Open-Angle
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
Dorzolamide 2 % eye drops solution
Additional drug interventions recognized in this trial
Dorzolamide
Tetrahydrozoline
More general drug interventions related to this trial
Antihypertensive Agents
Autonomic Agents
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nasal Decongestants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Alfred E. Tiefenbacher (GmbH & Co. KG)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services